Muzaffer Degertekin, MD

Effectiveness of the Sirolimus-Eluting Stent in the Treatment of Saphenous Vein Graft Disease

08/01/2008

Francesco Saia , MD, PhD;

Angela Hoye , MB, MRCP, MD, MBChB;

Pedro A. Lemos , MD;

Patrick W. Serruys , MD, PhD;

Chourmouzios A. Arampatzis , MD;

Muzaffer Degertekin , MD;

Sjoerd H. Hofma , MD;

Eugene P. McFadden , MB, MD;

Georgios Sianos , MD, PhD;

Pieter C. Smits , MD, PhD;

Kengo Tanabe , MD;

Willem J. van der Giessen , MD, PhD;

Pim J. de Feyter , MD, PhD;

Ron T. van Domburg , PhD;

ABSTRACT: The use of bare stents for the percutaneous intervention of saphenous vein bypass grafts (SVGs) is associated with a high subsequent rate of restenosis. To assess the impact of the sirolimus-eluting stent (SES), we studied 19...

ABSTRACT: The use of bare stents...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Collateral Formation in Patients After Percutaneous Myocardial Revascularization: A Mechanism for Improvement?

08/01/2008

Patrick W. Serruys , MD, PhD;

Muzaffer Degertekin , MD;

Pieter C. Smits , MD, PhD;

Kengo Tanabe , MD;

Willem J. van der Giessen , MD, PhD;

Ron T. van Domburg , PhD;

Chi-Hang Lee , MD, MBBS, MRCP;

Percutaneous myocardial revascularization (PMR) has emerged as a less invasive alternative to the transmyocardial revascularization (TMR), which requires thoracotomy. Initial results of PMR are encouraging with a significant proportion of...

Percutaneous myocardial...

08/01/2008

Journal of Invasive Cardiology